You are here

Article info

Article menu
XML
Short report
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

Authors

  • Joshua E Reuss Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Valsamo Anagnostou Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Tricia R Cottrell Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Kellie N Smith The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Franco Verde Department of Radiology, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Marianna Zahurak Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Mara Lanis Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Joseph C Murray Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Hok Yee Chan The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Caroline McCarthy Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Daphne Wang Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA Department of Pathology, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • James R White Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Stephen Yang Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Richard Battafarano Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Stephen Broderick Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Errol Bush Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Malcolm Brock Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Jinny Ha Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • David Jones Thoracic Surgery Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Taha Merghoub Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York, USA Weill Cornell Medical College, New York, New York, USA PubMed articlesGoogle scholar articles
  • Janis Taube Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA Department of Pathology, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Victor E Velculescu Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Gary Rosner Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Peter Illei Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA Department of Pathology, Johns Hopkins, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Drew M Pardoll Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Suzanne Topalian Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Jarushka Naidoo Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Ben Levy Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Matthew D Hellmann Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA Weill Cornell Medical College, New York, New York, USA PubMed articlesGoogle scholar articles
  • Julie R Brahmer Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Jamie E Chaft Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA Weill Cornell Medical College, New York, New York, USA PubMed articlesGoogle scholar articles
  • Patrick M Forde Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA The Bloomberg–Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Patrick M Forde; Pforde1{at}jhmi.edu
View Full Text

Citation

Reuss JE, Anagnostou V, Cottrell TR, et al
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
Journal for ImmunoTherapy of Cancer 2020;8:e001282. doi: 10.1136/jitc-2020-001282

Publication history

  • Accepted August 5, 2020
  • First published September 13, 2020.
Online issue publication 
September 13, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.